Search and Filter
Results per Page:
For dual-host alphaviruses, it’s a balancing act
From Malik Lab, Basic Sciences Division
Paddles, door handles, and a DNA-modifying protein called BsaXI
From Stoddard Lab, Basic Sciences Division
Secondary cancer risk following transplant-related immune suppression
From Drs. Phuong Vo and Rainer Storb, Clinical Research Division
Current landscape of metastatic triple-negative breast cancer survival rates
From the Hurvitz Lab, Clinical Research Division
Conditionally activated immunotherapies alleviate cancer treatment toxicity
From the Fong Lab, Translational Sciences and Therapeutics
Improving delivery of monoclonal antibody therapies in resource-limited settings
From researchers in the Translational Sciences and Therapeutics and Vaccines and Infectious Disease Divisions
KEAP-ing chemoresistance at bay in SCLC
From the MacPherson Lab, Human Biology Division
Switching Off to Survive: Unraveling KAT5’s Control of Glioblastoma Dormancy
From the Paddison Lab, Human Biology Division
At the intersection of Mpox and HIV infection: there is hope
From the HIV Outcomes, Prevention, and Epidemiology (HOPE) Group, Vaccine and Infectious Disease Division in collaboration with the Center for AIDS Research Network of Integrated Clinic Systems (CFAR CNICS)
Dysregulated and dysfunctional: T cell immunity in BV
From the Lund Lab, Vaccine and Infectious Disease Division
Un replanteamiento de la regulación génica que va más allá de los planos
Del Laboratorio Hahn, División de Ciencias Básicas
Immune clues in the tumor: how T cells may help predict colon cancer survival
From the Phipps research group, Public Health Sciences Division
When to start colonoscopy screening? A massive study backs starting at 45
From the Rutter research group, Public Health Sciences Division
Rethinking gene regulation: Beyond the blueprint
From the Hahn Lab, Basic Sciences Division
La hipertranscripción predice los resultados del cáncer gracias al Pol II
Del Laboratorio Henikoff, División de Ciencias Básicas
Git-ting it together: Using GitHub to enhance reproducibility
From the Subramaniam Lab, Basic Sciences Division
A tale of two T-cells: comparing liso-cel and axi-cel for treatment of refractory large B-cell lymphoma
From the Gauthier group, Clinical Research Division
Pediatric cancer survivors have a higher risk of chronic health conditions
From Dr. Wendy Liesenring, Clinical Research Division
Cytomegalovirus has an activity shift following CAR T-cell therapy
From the Hill Group, Vaccine and Infectious Disease and Clinical Research Divisions
Targeting the Integrator complex improves reactivation of HIV
From the Emerman Lab, Human Biology Division